JNJ – Johnson & Johnson

Latest News & Stock Analysis

Johnson & Johnson (JNJ) is a global healthcare giant, operating in pharmaceuticals, medical devices, and consumer health products. Founded in 1886, JNJ has built a diversified business model focused on developing and marketing innovative healthcare solutions. The company’s strength lies in its ability to generate consistent revenue streams across its various segments, making it a stable investment option for those interested in healthcare stocks. Stay updated with the latest news on JNJ, market trends, and in-depth stock analysis to inform your investment decisions.

Johnson & Johnson Beats Estimates, Raises Guidance
JNJ

Johnson & Johnson Beats Estimates, Raises Guidance

by | 16/04/2025 07:25 AM | JNJ

📈 Pharmaceutical giant Johnson & Johnson surpassed market expectations, reporting adjusted earnings of $2.77 per share, higher than the $2.69 estimated by analysts.

💰 Quarterly sales saw a healthy increase of 2.4%, aligning with forecasts and demonstrating steady business performance.

⬆️ The company revised its operational sales projection for the year upwards, increasing the forecast to $92 billion from approximately $91.3 billion.

Read more!